Evidence map›Paper›PMID 33424367›Full record

ArticleSaudi journal of biological sciences2021

Diabetic retinopathy in the Eastern Morocco: Different stage frequencies and associated risk factors.

Jamila Hammoudi, Nour El Houda Bouanani, El Habri Chelqi, Yassamine Bentata, Hamid Nouayti, Abdelkhaleq Legssyer, Abderrahim Ziyyat

Open access · hybridAbstract read
In one paragraph

Article in Saudi journal of biological sciences, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.0field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Jamila HammoudiLaboratoire de Bioressources, Biotechnologies, Ethnopharmacologie et Santé, Département de Biologie - Faculté des Sciences, Université Mohammed Premier, Oujda, Morocco.
Nour El Houda BouananiLaboratoire de Bioressources, Biotechnologies, Ethnopharmacologie et Santé, Département de Biologie - Faculté des Sciences, Université Mohammed Premier, Oujda, Morocco.
El Habri ChelqiService d'Ophtalmologie, Clinique Al-Irfane-Oujda, Morocco.
Yassamine BentataService de Néphrologie, CHU Mohammed VI, Oujda, Morocco.
Hamid NouaytiLaboratoire de Bioressources, Biotechnologies, Ethnopharmacologie et Santé, Département de Biologie - Faculté des Sciences, Université Mohammed Premier, Oujda, Morocco.
Abdelkhaleq LegssyerLaboratoire de Bioressources, Biotechnologies, Ethnopharmacologie et Santé, Département de Biologie - Faculté des Sciences, Université Mohammed Premier, Oujda, Morocco.
Abderrahim ZiyyatLaboratoire de Bioressources, Biotechnologies, Ethnopharmacologie et Santé, Département de Biologie - Faculté des Sciences, Université Mohammed Premier, Oujda, Morocco.
Premier University · BDCentre Hospitalier Universitaire Mohammed VI · MA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetes is a major cause of morbidity and mortality worldwide. It can affect many organs and, over time, leads to serious complications. Diabetic retinopathy (DR), a specific ocular complication of diabetes, remains the leading cause of vision loss and vision impairment in adults. This work is the first in Eastern Morocco aimed at identifying the different stages of DR and to determine their frequencies and associated risk factors. It is a case-control study conducted from December 2018 to July 2019 at the ophthalmology department of Al-Irfane Clinic (Oujda). Data were obtained from a specific questionnaire involving 244 diabetic patients (122 cases with retinopathy vs 122 controls without retinopathy). All results were analyzed by the EPI-Info software. This study shows a predominance of proliferative diabetic retinopathy (PDR) with 57.4% of cases (uncomplicated proliferative diabetic retinopathy (UPDR): 23.8%; complicated proliferative diabetic retinopathy (CPDR): 33.6%). The non-proliferative diabetic retinopathy (NPDR) represents 42.6% (minimal NPDR: 8.2%; moderate NPDR: 26.2%; severe NPDR: 8.2%). The determinants of DR were insulin therapy, high blood pressure, poor glycemic control and duration of diabetes. Regarding the chronological evolution, retinopathy precedes nephropathy. Diabetic nephropathy (DN) was present in 10.6% of cases especially in patients with PDR. In summary, the frequency of PDR was higher than that of NPDR. DR appears before DN with a high frequency of DN in patients with PDR. Good glycemic control and blood pressure control, as well as early diagnosis are the major preventive measures against DR.

Indexed as

Diabetic nephropathyDiabetic retinopathyEastern MoroccoRisk factors

Identifiers

PMID33424367
PMCPMC7783821
OpenAlexW3101539974

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.